FeesSafety
Pluang+

Canadian ALS Society advances national genetics strategy with TD funding renewal

Others
12 Nov 2026, 21:00 WIB
Na
View Source
Neutral
Canadian ALS Society advances national genetics strategy with TD funding renewal

The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that created the first national ALS genetics advisor position in Canada, aiming to integrate scientific advances with patient support. The funding supports ongoing genetic counseling services, new testing approaches, and development of care models tailored to genetic risks. This effort is crucial as genetic research opens new treatment possibilities, including therapies that slow disease progression for certain genetic forms of ALS.

The Canadian ALS Society's national genetics strategy for ALS is highlighted here with Pluang's health sector market data as context. For readers following health stocks, as of Nov 12, 2026 20:12 WIB, 82 of 150 US health-sector stocks rose while 64 fell. Notable movers include BNGO at USD 1.15 with a 4.55% gain and a typical hold time of 52 days, TXG at USD 59.30 down 4.43% with a 92-day hold, and INO at USD 1.42 down 3.73% with a 41-day hold.

More News

Interlink Electronics reports Q3 2026 revenue growth and plans transformative acquisition closing in Q4

Interlink Electronics reports Q3 2026 revenue growth and plans transformative acquisition closing in Q4

Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...

Company Fundamentals
Neutral
14 minutes ago
ALS Canada expands national genetics strategy with TD support to improve care and counselling.

ALS Canada expands national genetics strategy with TD support to improve care and counselling.

ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...

Others
Neutral
14 minutes ago
CollPlant to trade as OPHI on Nasdaq, focusing on photonic computing with LightSolver's laser tech.

CollPlant to trade as OPHI on Nasdaq, focusing on photonic computing with LightSolver's laser tech.

CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...

Market News
Bullish
1 hour ago
Evaxion announces its 2027 financial calendar with key dates for updates and results.

Evaxion announces its 2027 financial calendar with key dates for updates and results.

Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...

Market News
Neutral
1 hour ago
Glider launches a permissionless platform for tokenized stocks amid public companies' rejection of SEC venues.

Glider launches a permissionless platform for tokenized stocks amid public companies' rejection of SEC venues.

Glider has introduced a global investing platform for tokenized stocks that operates permissionlessly, bypassing the SEC's Tokenized Securities Venues (TSVs) which 50 public companies recently rejected. Backed by major investors like a16z and Coinbas...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App